胃腺癌致反复反流及18F-FDG PET/CT示肌肉高代谢
本文报告一例36岁男性,反复进行性反流,诊断为胃腺癌。18F-FDG PET/CT显示原发肿瘤及肋间肌和胸锁乳突肌摄取增高。结合临床病史和检查,该摄取模式有助于鉴别生理性变异与病理性原因。
要点
- 骨骼肌FDG摄取可由生理或病理原因引起,需结合临床背景解读。
- 胃腺癌患者可因反复反流导致肋间肌和胸锁乳突肌FDG摄取增高。
- 结合病史和体检有助于区分生理性变异与病理性肌肉摄取。
核心结论
- 骨骼肌FDG摄取需结合临床背景解读,以避免误诊。
研究设计与样本
- 本文为个案报告,报告一例36岁男性胃腺癌患者。
主要发现
- 18F-FDG PET/CT显示原发肿瘤及肋间肌和胸锁乳突肌 tracer 摄取增高。
- 患者表现为进行性、反复发作的反流。
临床怎么用
- 解读骨骼肌FDG摄取时需结合临床病史和检查,鉴别生理性变异与病理性原因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Skeletal muscle uptake of F-FDG can result from a variety of physiologic and pathologic conditions. It is important for the physician to interpret these uptake patterns in the correct context to avoid a misdiagnosis. We present a case of a 36-year-old man with progressive, repeated episodes of regurgitation who was diagnosed with adenocarcinoma of the stomach. F-FDG PET/CT showed increased tracer uptake in the primary tumor and in the intercostal and sternocleidomastoid muscles. The pattern of tracer uptake along with the clinical history and examination of the patient helped differentiate a physiologic variant from a pathologic cause.
引用
- Parihar AS, Vadi SK, Kumar R, et al. Adenocarcinoma of the Stomach Leading to Recurrent Regurgitation and Muscular Hypermetabolism on 18F-FDG PET/CT. Clin Nucl Med. 2019. PMID: 31274559. doi:10.1097/RLU.0000000000002681
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。